Phase II Trial of Lapatinib and Weekly Paclitaxel for Advanced Platinum Refractory Urothelial Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lapatinib; Paclitaxel
- Indications Bladder cancer
- Focus Biomarker; Therapeutic Use
- 17 Jan 2013 Biomarkers information updated
- 16 Jan 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Oct 2012 New trial record